The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity-Reference-Cited by-同舟云学术

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

Published:2010-09 Issue:3 Volume:8 Page:271-283
ISSN:1931-3128
Container-title:Cell Host & Microbe
language:en
Short-container-title:Cell Host & Microbe

Author:

Beltramello Martina,Williams Katherine L.,Simmons Cameron P.,Macagno Annalisa,Simonelli Luca,Quyen Nguyen Than Ha,Sukupolvi-Petty Soila,Navarro-Sanchez Erika,Young Paul R.,de Silva Aravinda M.,Rey Félix A.,Varani Luca,Whitehead Stephen S.,Diamond Michael S.,Harris Eva,Lanzavecchia Antonio,Sallusto Federica

Publisher

Elsevier BV

Subject

Virology,Microbiology,Parasitology

Reference64 articles.

1. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification;Balsitis;PLoS Pathog.,2010

2. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein;Beasley;J. Virol.,2002

3. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein;Bhardwaj;J. Virol.,2001

4. Dengue in Vietnamese infants—results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity;Chau;J. Infect. Dis.,2008

5. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants;Chau;J. Infect. Dis.,2009

Cited by 499 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preexisting inter-serotype immunity drives antigenic evolution of dengue virus serotype 2;Virology;2024-02

2. Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus;Communications Biology;2024-01-24

3. Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine;Vaccines;2024-01-17

4. Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination;Cell Host & Microbe;2023-11

5. Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick‐borne encephalitis and dengue virus infections;Journal of Medical Virology;2023-11